- Home
- PIPR vs APLS Comparison
PIPR vs APLS Comparison
Compare PIPR & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIPR
- APLS
- Stock Information
- Founded
- PIPR 1895
- APLS 2009
- Country
- PIPR United States
- APLS United States
- Employees
- PIPR N/A
- APLS N/A
- Industry
- PIPR Investment Bankers/Brokers/Service
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- PIPR Finance
- APLS Health Care
- Exchange
- PIPR Nasdaq
- APLS Nasdaq
- Market Cap
- PIPR 4.6B
- APLS 4.4B
- IPO Year
- PIPR N/A
- APLS 2017
- Fundamental
- Price
- PIPR $336.53
- APLS $26.27
- Analyst Decision
- PIPR Buy
- APLS Buy
- Analyst Count
- PIPR 3
- APLS 18
- Target Price
- PIPR $193.00
- APLS $51.00
- AVG Volume (30 Days)
- PIPR 126.4K
- APLS 3.5M
- Earning Date
- PIPR 10-25-2024
- APLS 11-05-2024
- Dividend Yield
- PIPR 0.77%
- APLS N/A
- EPS Growth
- PIPR 122.99
- APLS N/A
- EPS
- PIPR 9.33
- APLS N/A
- Revenue
- PIPR $1,513,658,000.00
- APLS $715,216,000.00
- Revenue This Year
- PIPR $13.28
- APLS $95.59
- Revenue Next Year
- PIPR $16.11
- APLS $13.77
- P/E Ratio
- PIPR $36.02
- APLS N/A
- Revenue Growth
- PIPR 19.45
- APLS 162.10
- 52 Week Low
- PIPR $151.03
- APLS $24.34
- 52 Week High
- PIPR $347.15
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- PIPR 66.54
- APLS 36.30
- Support Level
- PIPR $278.14
- APLS $24.34
- Resistance Level
- PIPR $344.64
- APLS $29.94
- Average True Range (ATR)
- PIPR 9.38
- APLS 1.66
- MACD
- PIPR 3.04
- APLS 0.08
- Stochastic Oscillator
- PIPR 84.61
- APLS 31.54
About PIPR Piper Sandler Companies
Piper Sandler Cos is an investment banking company. Investment banking services include financial advisory services, management of and participation in underwriting, and public finance activities. It generates maximum revenue from Advisory services followed by Equity financing. The company focuses on the following sectors: healthcare; energy; consumer; diversified industrials and services; business services; technology; financial services; agriculture, clean technologies, and renewables, focusing on middle-market clients.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.